{"id":23259,"date":"2023-08-29T11:56:31","date_gmt":"2023-08-29T18:56:31","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23259"},"modified":"2024-01-30T23:50:10","modified_gmt":"2024-01-30T23:50:10","slug":"ivig-and-myositis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/","title":{"rendered":"IgIV y miositis"},"content":{"rendered":"<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-to-expect-during-your-ivig-infusion-treatment\/\">Terapia con inmunoglobulina intravenosa (IVIG)<\/a> Se ha convertido en un tratamiento prometedor para la miositis, a menudo conocida colectivamente como miopat\u00edas inflamatorias idiop\u00e1ticas (MII). La miositis representa un grupo de enfermedades autoinmunes raras que causan inflamaci\u00f3n cr\u00f3nica y debilidad muscular. Los s\u00edntomas de esta afecci\u00f3n debilitante pueden aparecer gradualmente con el tiempo y afectar significativamente la calidad de vida del paciente.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-c55081efca2ba0bfc38f0b46c527179f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">Cada a\u00f1o, alrededor de <\/span><a href=\"https:\/\/www.hss.edu\/condition-list_myositis.asp#:~:text=People%20in%20younger%20(25%20to,United%20States%20who%20have%20it.\"><span style=\"font-weight: 400;\">7.000 personas reciben un diagn\u00f3stico de miositis y hay m\u00e1s de 50.000 individuos en los Estados Unidos<\/span><\/a><span style=\"font-weight: 400;\"> viviendo con esta condici\u00f3n. Seg\u00fan <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7034746\/#:~:text=There%20are%20several%20theories%20on,suppression%20or%20blockage%20%5B4%5D.\"><span style=\"font-weight: 400;\">ensayos doble ciego y controlados con placebo<\/span><\/a><span style=\"font-weight: 400;\">Se ha descubierto que la terapia con IgIV es eficaz para controlar los s\u00edntomas de la miositis.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Este art\u00edculo proporciona una comprensi\u00f3n integral de la miositis, c\u00f3mo se produce, sus tipos y c\u00f3mo la terapia con inmunoglobulina intravenosa (IVIG) puede ofrecer esperanza y alivio a quienes padecen esta desafiante afecci\u00f3n.<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#Understanding_Myositis\" >Entendiendo la miositis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Causes_Myositis\" >\u00bfQu\u00e9 causa la miositis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Are_the_Common_Types_of_Myositis\" >\u00bfCu\u00e1les son los tipos comunes de miositis?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#IVIG_Therapy_A_Promising_Approach_for_Myositis_Treatment\" >Terapia con IgIV: un enfoque prometedor para el tratamiento de la miositis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Is_IVIG\" >\u00bfQu\u00e9 es la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#How_Does_IVIG_Work\" >\u00bfC\u00f3mo funciona la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Types_of_Myositis_Can_IVIG_Be_Used_To_Treat\" >\u00bfQu\u00e9 tipos de miositis se pueden tratar con IgIV?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Is_the_Standard_Dose_of_IVIG_for_Myositis_Patients\" >\u00bfCu\u00e1l es la dosis est\u00e1ndar de IgIV para pacientes con miositis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#Are_There_Any_Side_Effects_Associated_With_IVIG\" >\u00bfExisten efectos secundarios asociados con la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#What_Is_the_Success_Rate_of_IVIG_in_Treating_Myositis\" >\u00bfCu\u00e1l es la tasa de \u00e9xito de la IgIV en el tratamiento de la miositis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#How_Often_Is_IVIG_Administered_for_Myositis_Treatment\" >\u00bfCon qu\u00e9 frecuencia se administra IgIV para el tratamiento de la miositis?&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/#Conclusion\" >Conclusi\u00f3n<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Understanding_Myositis\"><\/span>Entendiendo la miositis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/myositis\/\">Miositis<\/a>, derivada de las palabras griegas \u00abmyo\u00bb (m\u00fasculo) e \u00abitis\u00bb (inflamaci\u00f3n), define conjuntamente una inflamaci\u00f3n muscular cr\u00f3nica y progresiva. En esta afecci\u00f3n autoinmune, el sistema inmunitario, encargado de proteger al cuerpo de invasores externos como virus y bacterias, ataca por error el tejido muscular sano, provocando debilidad, dolor y fatiga.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La hinchaz\u00f3n, la debilidad muscular, el dolor y las erupciones cut\u00e1neas son los s\u00edntomas m\u00e1s comunes de la miositis.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La miositis puede ocurrir a cualquier edad, pero es m\u00e1s com\u00fan en adultos entre 30 y 60 a\u00f1os.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Causes_Myositis\"><\/span><b>\u00bfQu\u00e9 causa la miositis?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La causa exacta de la miositis a\u00fan se desconoce, pero los investigadores creen que implica una <\/span><a href=\"http:\/\/arthritis.org\/diseases\/myositis\"><span style=\"font-weight: 400;\">combinaci\u00f3n de factores gen\u00e9ticos y ambientales<\/span><\/a><span style=\"font-weight: 400;\">Algunos factores de riesgo potenciales incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Desencadenantes gen\u00e9ticos: <\/b><span style=\"font-weight: 400;\">Ciertos marcadores gen\u00e9ticos pueden aumentar la probabilidad de desarrollar miositis.<\/span><\/li>\n\n\n\n<li><b>Disfunci\u00f3n del sistema inmunol\u00f3gico:<\/b><span style=\"font-weight: 400;\"> La miositis a menudo se clasifica como un trastorno autoinmune, en el que el sistema inmunitario lesiona por error los tejidos musculares y provoca debilidad muscular.<\/span><\/li>\n\n\n\n<li><b>Factores desencadenantes ambientales:<\/b><span style=\"font-weight: 400;\"> Infecciones como <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2493084\/#:~:text=The%20most%20common%20fungal%20agent,**%2C%20occasionally%20causes%20myositis.\"><span style=\"font-weight: 400;\">infecci\u00f3n viral<\/span><\/a><span style=\"font-weight: 400;\"> o la exposici\u00f3n a ciertos medicamentos (estatinas) y drogas ilegales como la coca\u00edna pueden desencadenar miositis en individuos susceptibles.<\/span><\/li>\n\n\n\n<li><b>Lesiones, traumatismos y c\u00e1ncer: <\/b><span style=\"font-weight: 400;\">&nbsp;Las lesiones, los traumatismos y el c\u00e1ncer tambi\u00e9n pueden desencadenar miositis debido al estr\u00e9s que ejercen sobre el cuerpo.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Common_Types_of_Myositis\"><\/span><b>\u00bfCu\u00e1les son los tipos comunes de miositis?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La miositis se clasifica en varios subtipos seg\u00fan sus caracter\u00edsticas espec\u00edficas, s\u00edntomas y causas subyacentes. Esta clasificaci\u00f3n ayuda a los m\u00e9dicos y profesionales de la salud a diagnosticar y tratar la afecci\u00f3n eficazmente. Las formas m\u00e1s comunes de miositis incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/polymyositis\/\">Polimiositis<\/a>:<\/b><span style=\"font-weight: 400;\"> Se caracteriza por la inflamaci\u00f3n de m\u00faltiples m\u00fasculos que afectan ambos lados del cuerpo, especialmente los hombros, las caderas y el cuello.<\/span><\/li>\n\n\n\n<li><b><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-amyopathic-dermatomyositis-adm\/\">Dermatomiositis<\/a>:<\/b><span style=\"font-weight: 400;\"> Este tipo presenta erupciones cut\u00e1neas, que pueden ser una pista diagn\u00f3stica esencial. La debilidad muscular suele aparecer m\u00e1s adelante.<\/span><\/li>\n\n\n\n<li><b>Miositis por cuerpos de inclusi\u00f3n espor\u00e1dicos (MBI):<\/b><span style=\"font-weight: 400;\"> Se trata de una forma progresiva de miositis, que suele presentarse en adultos mayores y que puede provocar debilidad muscular grave y dificultad para tragar.<\/span><\/li>\n\n\n\n<li><b>Miopat\u00eda necrosante:<\/b><span style=\"font-weight: 400;\"> Los pacientes de esta categor\u00eda suelen tener biopsias que muestran menos inflamaci\u00f3n que con polimiositis; sin embargo, presentan una mayor incidencia de muerte celular. Al igual que la polimiositis, esta causa debilidad muscular en el tronco.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_Therapy_A_Promising_Approach_for_Myositis_Treatment\"><\/span>Terapia con IgIV: un enfoque prometedor para el tratamiento de la miositis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Aunque no existe cura para la miositis, ciertos medicamentos inmunosupresores y corticosteroides suelen recetarse como tratamiento de primera l\u00ednea para controlar los s\u00edntomas de esta afecci\u00f3n. Sin embargo, en algunos casos, cuando <\/span><span style=\"font-weight: 400;\">Los corticosteroides y los inmunosupresores est\u00e1ndar no funcionan eficazmente o est\u00e1n contraindicados, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">inmunoglobulina intravenosa (IVIG)<\/a> Se opta como terapia alternativa o tratamiento complementario.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">IgIV <\/span><span style=\"font-weight: 400;\">Es el \u00fanico tratamiento seguro, eficaz y bien tolerado para diversas formas de miositis. Esta terapia ha demostrado efectos beneficiosos en el control de los s\u00edntomas de la miositis, la modulaci\u00f3n de la respuesta inmunitaria, la reducci\u00f3n de la inflamaci\u00f3n y la prevenci\u00f3n de mayor da\u00f1o muscular.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_IVIG\"><\/span><b>\u00bfQu\u00e9 es la IgIV?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV es una soluci\u00f3n concentrada de inmunoglobulinas, que son anticuerpos derivados del plasma sangu\u00edneo de donantes sanos. Estas inmunoglobulinas ayudan a fortalecer el sistema inmunitario y pueden modular la respuesta autoinmunitaria que provoca miositis.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Adem\u00e1s, varios estudios han demostrado que la IgIV puede producir mejoras en la fuerza muscular, la resistencia y la funci\u00f3n f\u00edsica general en pacientes con miositis.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-a9f90108692f49b0f37a95e681d951fb\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tPregunte sobre la infusi\u00f3n de IgIV en el hogar\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Consulte a un especialista en IgIV<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Work\"><\/span><b>\u00bfC\u00f3mo funciona la IgIV?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig.jpg\" alt=\"View of the IVIG bottle during an infusion\" class=\"wp-image-23262\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/ivig-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">El mecanismo de acci\u00f3n exacto por el cual la terapia con IgIV beneficia a los pacientes con miositis a\u00fan no est\u00e1 claro. Sin embargo, existen varias teor\u00edas propuestas sobre c\u00f3mo la IgIV podr\u00eda ejercer sus efectos terap\u00e9uticos:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Modulaci\u00f3n inmunol\u00f3gica:<\/b><span style=\"font-weight: 400;\"> La IgIV contiene una gama diversa de anticuerpos que pueden regular el sistema inmunitario. Esto puede ayudar a suprimir la respuesta inmunitaria err\u00f3nea responsable de atacar los m\u00fasculos.<\/span><\/li>\n\n\n\n<li><b>Neutralizaci\u00f3n de anticuerpos:<\/b><span style=\"font-weight: 400;\"> La IgIV puede contener anticuerpos que neutralizan los autoanticuerpos da\u00f1inos producidos por el sistema inmunitario. Esto podr\u00eda reducir la inflamaci\u00f3n muscular y limitar el da\u00f1o muscular.<\/span><\/li>\n\n\n\n<li><b>Efectos antiinflamatorios:<\/b><span style=\"font-weight: 400;\"> La IgIV tambi\u00e9n podr\u00eda tener efectos antiinflamatorios directos, reduciendo la inflamaci\u00f3n general en los m\u00fasculos.<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Types_of_Myositis_Can_IVIG_Be_Used_To_Treat\"><\/span><b>\u00bfQu\u00e9 tipos de miositis se pueden tratar con IgIV?&nbsp;<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV se ha utilizado como opci\u00f3n de tratamiento para diversos tipos de miositis, como la polimiositis (PM), la dermatomiositis (DM), la miositis por cuerpos de inclusi\u00f3n (MIC) y la miositis juvenil (MJ), menos frecuente. Esta terapia no cura la miositis, pero puede ayudar a aliviar los s\u00edntomas para que los pacientes puedan llevar una vida menos dolorosa.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Standard_Dose_of_IVIG_for_Myositis_Patients\"><\/span><b>\u00bfCu\u00e1l es la dosis est\u00e1ndar de IgIV para pacientes con miositis?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis inicial de IgIV se administra t\u00edpicamente por v\u00eda intravenosa durante 2 a 5 d\u00edas a una velocidad de 2 g\/kg. A esto le sigue una dosis de mantenimiento de 1 g\/kg al mes durante varios meses. Dependiendo de la respuesta al tratamiento, la dosis de IgIV puede reducirse gradualmente durante varios meses m\u00e1s. La dosis de IgIV, la velocidad de infusi\u00f3n y los ciclos de IgIV se establecen seg\u00fan el estado de salud del paciente y la gravedad de los s\u00edntomas de miositis.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Are_There_Any_Side_Effects_Associated_With_IVIG\"><\/span><b>\u00bfExisten efectos secundarios asociados con la IgIV?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Si bien el tratamiento con IgIV suele ser seguro y bien tolerado, tambi\u00e9n presenta algunos posibles efectos secundarios. Los pacientes con miositis pueden experimentar malestar general, s\u00edntomas gripales, cefaleas leves, escalofr\u00edos, fiebre y dolor articular. Estos efectos secundarios suelen ser temporales y desaparecen a los pocos d\u00edas del tratamiento.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Adem\u00e1s, en casos raros, algunos pacientes pueden experimentar una reacci\u00f3n a la infusi\u00f3n, que causa s\u00edntomas como urticaria, dificultad para respirar o incluso una reacci\u00f3n al\u00e9rgica grave (anafilaxia). A menudo, para mitigar una posible reacci\u00f3n a la infusi\u00f3n, los m\u00e9dicos recetan Benadryl y Tylenol antes de la infusi\u00f3n. Las reacciones a la infusi\u00f3n se presentan principalmente en pacientes con deficiencia de IgA. Por lo tanto, se recomienda evaluar la deficiencia de IgA en pacientes con miositis antes de iniciar el tratamiento con IgIV.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Success_Rate_of_IVIG_in_Treating_Myositis\"><\/span><b>\u00bfCu\u00e1l es la tasa de \u00e9xito de la IgIV en el tratamiento de la miositis?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La tasa de \u00e9xito de la IgIV en el tratamiento de la miositis puede variar dependiendo de varios factores, incluido el tipo espec\u00edfico de miositis, la respuesta individual del paciente al tratamiento y la gravedad de la enfermedad.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Por ejemplo, un ensayo controlado aleatorio publicado en <\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2117912\"><span style=\"font-weight: 400;\">La Revista de Medicina de Nueva Inglaterra<\/span><\/a><span style=\"font-weight: 400;\"> demostr\u00f3 que <\/span><b>La IgIV fue eficaz en el tratamiento de pacientes con dermatomiositis<\/b><span style=\"font-weight: 400;\">, una forma espec\u00edfica de miositis. El estudio revel\u00f3 que los pacientes que recibieron IgIV experimentaron una mejora significativa en la fuerza muscular y una disminuci\u00f3n de los niveles de enzimas musculares, lo que indica una reducci\u00f3n de la inflamaci\u00f3n muscular.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">De manera similar, otro <\/span><a href=\"https:\/\/n.neurology.org\/content\/84\/14_Supplement\/P7.047\"><span style=\"font-weight: 400;\">estudiar<\/span><\/a><span style=\"font-weight: 400;\">Los resultados sugieren que el tratamiento con IgIV a largo plazo es eficaz para mejorar la fuerza muscular y mantener la capacidad de caminar en pacientes con sIBM.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Often_Is_IVIG_Administered_for_Myositis_Treatment\"><\/span><b>\u00bfCon qu\u00e9 frecuencia se administra IgIV para el tratamiento de la miositis?&nbsp;<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La frecuencia y la dosis de la terapia con IgIV var\u00edan seg\u00fan la gravedad de la miositis y la respuesta del paciente al tratamiento. Algunas personas pueden requerir infusiones de IgIV mensuales, mientras que otras pueden recibirlas a intervalos m\u00e1s prolongados.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-11eccc11794f2bbccaf34590dee63100\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfPuede ayudar la IgIV?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n gratuita sobre el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusi\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">En resumen, la miositis es una afecci\u00f3n compleja que puede afectar significativamente la calidad de vida de una persona. Sin embargo, gracias a los avances en la ciencia m\u00e9dica, tratamientos como la IgIV ofrecen esperanza a los pacientes con miositis. Al modular la respuesta inmunitaria y reducir la inflamaci\u00f3n muscular, la terapia con IgIV puede proporcionar alivio y potencialmente mejorar los s\u00edntomas asociados con la miositis.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La terapia con inmunoglobulina intravenosa (IGIV) se ha convertido en un tratamiento prometedor para la miositis, a menudo conocida colectivamente como miopat\u00edas inflamatorias idiop\u00e1ticas (MII). La miositis representa un grupo de enfermedades autoinmunes raras que causan inflamaci\u00f3n cr\u00f3nica y debilidad muscular.<\/p>","protected":false},"author":27,"featured_media":23261,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[33],"class_list":["post-23259","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG and Myositis - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Explore the promising role of IVIG therapy in treating myositis, a rare autoimmune disease causing muscle weakness and inflammation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG and Myositis - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Explore the promising role of IVIG therapy in treating myositis, a rare autoimmune disease causing muscle weakness and inflammation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-29T18:56:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-30T23:50:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"IVIG and Myositis\",\"datePublished\":\"2023-08-29T18:56:31+00:00\",\"dateModified\":\"2024-01-30T23:50:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/\"},\"wordCount\":1244,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/myositis.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/\",\"name\":\"IVIG and Myositis - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/myositis.jpg\",\"datePublished\":\"2023-08-29T18:56:31+00:00\",\"dateModified\":\"2024-01-30T23:50:10+00:00\",\"description\":\"Explore the promising role of IVIG therapy in treating myositis, a rare autoimmune disease causing muscle weakness and inflammation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/myositis.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/myositis.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Woman with myositis massaging neck\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-myositis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG and Myositis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV y miositis - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Explore el papel prometedor de la terapia con IgIV en el tratamiento de la miositis, una enfermedad autoinmune rara que causa debilidad e inflamaci\u00f3n muscular.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG and Myositis - AmeriPharma\u00ae Specialty Care","og_description":"Explore the promising role of IVIG therapy in treating myositis, a rare autoimmune disease causing muscle weakness and inflammation.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-myositis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-08-29T18:56:31+00:00","article_modified_time":"2024-01-30T23:50:10+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"IVIG and Myositis","datePublished":"2023-08-29T18:56:31+00:00","dateModified":"2024-01-30T23:50:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/"},"wordCount":1244,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/","name":"IgIV y miositis - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg","datePublished":"2023-08-29T18:56:31+00:00","dateModified":"2024-01-30T23:50:10+00:00","description":"Explore el papel prometedor de la terapia con IgIV en el tratamiento de la miositis, una enfermedad autoinmune rara que causa debilidad e inflamaci\u00f3n muscular.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg","width":1280,"height":853,"caption":"Woman with myositis massaging neck"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-myositis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG and Myositis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"Intravenous immunoglobulin (IVIG) therapy has emerged as a promising treatment for myositis, often collectively known as idiopathic inflammatory myopathies (IIMs). Myositis represents a group of rare autoimmune diseases that causes chronic inflammation and weakness in the muscles.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/myositis.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Intravenous immunoglobulin (IVIG) therapy has emerged as a promising treatment for myositis, often collectively known as idiopathic inflammatory myopathies (IIMs). Myositis represents a group of rare autoimmune diseases that causes chronic inflammation and weakness in the muscles.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23259"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23259\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23261"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23259"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}